Publications by authors named "Ida Colantonio"

Claim this Profile
P
Predictors of duration of hospital stay for cancer patients admitted due to medical causes: A quality-improvement evaluation.
Gianmauro Numico, Elena Fea, Rachele Ferrua, Michela Milanesio, Giulia Bernardi, Ida Colantonio

Tumori· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer.
Jessica Menis, Laurent Greiller, Pierre Demontrond, Isabelle Monnet, Silvia Novello, Ida Colantonio

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE study.
Giuseppe Lamberti, Karim Rihawi, Francesca Mazzoni, Ferdinando Riccardi, Alessandro Follador, Ida Colantonio

J Immunother Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION group.
Chiara Catania, Claudia Proto, Chiara Bennati, Salvatore Grisanti, Ida Colantonio

Crit Rev Oncol Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-2016.
Francesco Gelsomino, Luca Boni, Marcello Tiseo, Serena Ricciardi, Danilo Rocco, Ida Colantonio

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with cancer and hospital admissions: disease trajectory and strategic choices.
Gianmauro Numico, Rachele Ferrua, Elena Fea, Jacopo Giamello, Ida Colantonio

BMJ Support Palliat Care· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of advanced non-small cell lung cancer in the era of immunotherapy approach: a multicenter Italian observational prospective study of biomarker screening in daily clinical practice.
Tiziana Vavala, Umberto Malapelle, Claudia Veggiani, Vienna Ludovini, Mauro Papotti, Ida Colantonio

J Clin Pathol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Elisa Andrini, Giuseppe Lamberti, Francesca Mazzoni, Ferdinando Riccardi, Andrea Bonetti, Ida Colantonio

Future Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Francesco Gelsomino, Marcello Tiseo, Fausto Barbieri, Ferdinando Riccardi, Luigi Cavanna, Ida Colantonio

Br J Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating patients with cancer amidst the COVID-19 pandemic: experience of a regional hospital in the Piedmont region in northern Italy.
Ornella Garrone, Nerina Denaro, Fiorella Ruatta, Paola Vanella, Cristina Granetto, Ida Colantonio

Tumori· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Francesco Gelsomino, Marcello Tiseo, Fausto Barbieri, Ferdinando Riccardi, Luigi Cavanna, Ida Colantonio

Br J Cancer· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial).
Francesco Gelsomino, Giuseppe Lamberti, Marcello Tiseo, Danilo Rocco, Giulia Pasello, Ida Colantonio

Ther Adv Med Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial.
Enrica Capelletto, Maria Rita Migliorino, Alessandro Morabito, Rita Chiari, Francesco Grossi, Ida Colantonio

Lung Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab-induced fulminant type 1 diabetes (T1D): the first Italian case report with long follow-up and flash glucose monitoring.
Francesco Tassone, Ida Colantonio, Elena Gamarra, Laura Gianotti, Claudia Baffoni

Acta Diabetol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged Drainage and Intrapericardial Bleomycin Administration for Cardiac Tamponade Secondary to Cancer-Related Pericardial Effusion.
Gianmauro Numico, Antonella Cristofano, Marcella Occelli, Marco Sicuro, Alessandro Mozzicafreddo, Ida Colantonio

Medicine (Baltimore)· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed versus pemetrexed and carboplatin as second-line chemotherapy in advanced non-small-cell lung cancer: results of the GOIRC 02-2006 randomized phase II study and pooled analysis with the NVALT7 trial.
Andrea Ardizzoni, Marcello Tiseo, Luca Boni, Andrew D Vincent, Rodolfo Passalacqua, Ida Colantonio

J Clin Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer.
Marco C Merlano, Martino Monteverde, Ida Colantonio, Nerina Denaro, Cristiana Lo Nigro

Oral Oncol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy.
Elvio G Russi, Marco C Merlano, Gianmauro Numico, Renzo Corvò, Marco Benasso, Ida Colantonio

Support Care Cancer· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 309 polymorphism predicts outcome in platinum-treated locally advanced head and neck cancer.
Daniela Vivenza, Milena Gasco, Martino Monteverde, Laura Lattanzio, Nelofer Syed, Ida Colantonio

Oral Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questions.
Nerina Denaro, Elvio G Russi, Vincenzo Adamo, Ida Colantonio, Marco C Merlano

Oncology· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival prediction and frequency of anticancer treatment in cancer patients hospitalized due to acute conditions. Role of clinical parameters and PaP score.
Gianmauro Numico, Marcella Occelli, Elvio G Russi, Nicola Silvestris, Raffaella Pasero, Ida Colantonio

Support Care Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy.
Gianmauro Numico, Elvio Grazioso Russi, Ida Colantonio, Rosa Anna Lantermo, Nicola Silvestris

Anticancer Res· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
Gianmauro Numico, Elvio G Russi, Raffele Vitiello, Raffaele Sorrentino, Ida Colantonio

Int J Radiat Oncol Biol Phys· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin and weekly paclitaxel in non-small cell lung cancer patients unfit for or pretreated with chemotherapy.
Gianmauro Numico, Ida Colantonio, Milena Gasco, Gianfilippo Bertelli, Ornella Garrone

Anticancer Res· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
Marco Merlano, Elvio G Russi, Gianmauro Numico, Ida Colantonio, Ornella Garrone

Radiother Oncol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis